GOLDEN RULES FOR TRADING

Pharma Stocks Outlook for the week – 03 to 07.08.2015

Pharma Stocks Outlook for the week – 03 to 07.08.2015
GSK Pharma, Sun Pharma seen down; Lupin seen up

Stocks of major pharmaceutical companies are seen trading based on company-specific triggers next week, with those of GlaxoSmithKline Pharma Ltd and Sun Pharmaceutical Industries Ltd seen underperforming their peers in the sector. Stocks of Sun Pharma, India's largest drug maker, have been on a negative run since the company announced that its revenues for 2015-16 (Apr-Mar) will Take a hit due to remediation charges incurred for the Halol plant and expenses undertaken for merger of Ranbaxy Laboratories Ltd.

Another stock that is seen trading down next week is GSK Pharma, which reported a 5.1% fall in its net profit to 932.8 mln rupees for the June quarter, missing the Street's expectations. Stocks of Lupin Ltd, which saw a sharp fall last week on disappointing the market with its Apr-Jun earnings, are seen up next week. Hyderabad-based Dr Reddy's Laboratories, which has touched lifetime high levels during this week, is seen continuing with the positive momentum.

The Mumbai-based drug manufacturer reported a meagre 3.3% on-year rise in its consolidated net profit for the June quarter, which was below the analysts' estimates. The stocks of the company, however, rose in yesterday's trade due to rollover of long positions to the stock's August derivative contracts.